Skip to content

Densityai

by Densitas Inc

510(k) K192973

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Special NumberK192973 Date19 Feb 2020ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
24 Oct 2019
FDA decision
19 Feb 2020 (Substantially Equivalent)
FDA review time
118 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K192973 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K192973 decided 19 Feb 2020 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

Full name
densitas densityai
510(k) Number
FDA product code
LLZ
FDA applicant
Densitas, Inc.
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Densityai is an AI-powered software tool designed for automated breast density assessment from mammographic images. Classified as a radiological imaging software (Product Code LLZ), it employs deep-learning algorithms to standardize and quantify breast density measurements, reducing variability inherent in visual radiologist interpretation. The device supports clinical decision-making by providing objective, reproducible density classifications aligned with established nomenclature standards. Its output aids in risk stratification and workflow optimization for breast cancer screening programs.

Densityai is supplied as a software application integrated into mammography systems, requiring no additional hardware. It operates in radiology departments and screening centers, processing digital mammograms to generate standardized density scores. The software is intended for single-use per image analysis, with no sterility or reprocessing requirements. Compliance with FDA 510(k) clearance (K192973) and EU MDR ensures its regulatory standing for use in diagnostic imaging workflows. No MRI safety considerations apply, as it is a non-invasive software solution.

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Densitas Inc

  • DM-Density

    Class II